Cornelius Schmaltz

Cornelius Schmaltz Deputy Head of Unit of the Fighting Infectious Diseases and Global Epidemics unit, European Commission Cornelius Schmaltz received his MD and his training as a board-certified paediatrician from the University of Freiburg/Germnany. Following a postdoc at Dana-Farber Cancer Institute in Boston and a fellowship in Pediatric Hematology/Oncology at Memorial Sloan-Kettering Cancer Center in [...]

Cornelius Schmaltz2015-05-08T13:10:18+02:00

Duane Schulthess

Duane Schulthess Managing Director Vital Transformation Duane Schulthess is the Managing Director of Vital Transformation, a consultancy that helps define the impact of new technologies and regulation in the health-care sector. He regularly works with National health authorities, multi-national corporations, governments, and stakeholder groups on healthcare policy and technology. He has been [...]

Duane Schulthess2017-08-10T07:56:48+02:00

Bettina Ryll

Bettina Ryll Founder, Melanoma Patient Network Europe Bettina Ryll founded the Melanoma Patient Network Europe in 2011. Bettina holds a medical degree and a Phd in biomedical sciences and the experience of her husband participating in several clinical trials after having been diagnosed with metastatic Melanoma at the age of 36 ultimately changed her [...]

Bettina Ryll2017-08-09T09:15:03+02:00

Jillian Oderkirk

Jillian Oderkirk Senior Analyst, Health Division, OECD Jillian Oderkirk is a Senior Economist and Policy Analyst with the Health Division of the Organisation for Economic Co-operation and Development in Paris, France. She leads a project on developing health information infrastructure including the development of electronic health record systems; the use of personal health data for [...]

Jillian Oderkirk2017-08-09T09:15:03+02:00

Sandrine Marreaud

Sandrine Marreaud Head of Medical and Pharmacovigilance Department, EORTC At the end of Medical School, after one year of Pharmaceutical Medicine program and a DES in management, S. Marreaud began her career as medical fellow at EORTC and had the opportunity to be exposed to full range of trainings, all of which tended to reinforce [...]

Sandrine Marreaud2015-05-08T13:14:13+02:00

Yann Le Cam

Yann Le Cam CEO, Eurordis Yann Le Cam is a patient advocate who has dedicated 25 years of professional and personal commitment to health and medical research non-governmental organisations in France, Europe and the United States in the fields of cancer, HIV/AIDS and rare diseases. He has three daughters, the eldest of whom has cystic [...]

Yann Le Cam2017-08-09T09:15:03+02:00

Faraz Kermani

Faraz Kermani Senior Editor Europe, Elsevier - The Pink Sheet Faraz Kermani is a a journalist and editor at the Pink Sheet, a US-based publication that covers the global pharmaceutical market. He has a B.A. (Hons) in German and Scandinavian Studies and an M.A. in European Law, with a specialisation in pharmaceutical law. He has [...]

Faraz Kermani2017-08-09T09:15:03+02:00

Alastair Kent

Alastair Kent Director, Genetic Alliance UK Alastair Kent OBE is the Director of Genetic Alliance UK – the national charity of over 150 patient organisations, supporting all those affected by genetic conditions. Genetic Alliance UK’s mission is to promote the development of the scientific understanding of genetics and the part that genetic factors play in [...]

Alastair Kent2015-09-08T12:50:50+02:00

Ryan Hohman

Ryan Hohman Managing Director, Policy & Public Affairs, Friends of Cancer Research Ryan Hohman, JD, serves as Managing Director, Policy & Public Affairs at Friends of Cancer Research (Friends), a think tank and advocacy organization based in Washington, D.C. Friends is our country’s leading voice in advocating for policies and proposing and promoting real solutions [...]

Ryan Hohman2015-10-26T10:33:22+02:00

Adam Healthfield

Adam Healthfield Director of Science Policy for Europe, Pfizer, UK Adam is Pfizer’s Director of Science Policy for Europe and works closely with the company’s R&D organisation to support European and global projects on orphan drugs and rare diseases, R&D productivity, collaborative research, stem cell science and personalised medicine. Adam has been a member of [...]

Adam Healthfield2017-08-09T09:15:03+02:00
Go to Top